跳至主要内容
临床试验/NCT06687161
NCT06687161招募中不适用

Neuromodulation and Cognitive Behavioral Therapy for Insomnia in MCI

Beth Israel Deaconess Medical Center2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
Insomnia Severity Index

研究概览

简要总结

The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy for insomnia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 60 years or older
  • Speak and read English
  • Clinical diagnosis of MCI or Subjective Cognitive Impairment (SCI)-a perceived gradual worsening in cognitive ability relative to one's younger self, or peer group-reported by either the participant or informant
  • Reported insomnia symptoms (sleep-onset and/or sleep maintenance) that cause significant distress or impairment in social, occupational, or other areas of functioning over the past three months
  • Have access to an Internet-enabled computer or tablet at home, or ability to connect a BIDMC-provided tablet to the internet, with private space to complete cognitive testing
  • Capable of and willing to provide written informed consent

排除标准

  • Evidence of significant cognitive impairment or dementia
  • Contraindications for TMS or MRI
  • Current psychological treatment for insomnia
  • Uncontrolled moderate-to-severe obstructive sleep apnea or other untreated sleep disorder (e.g., Restless Leg Syndrome, Periodic Limb Movement Disorder, parasomnia). Sleep apnea that is managed (e.g., regular use of a CPAP) and stable for ≥3 months is allowed.
  • Diagnosis of Parkinson's disease, Huntington's disease, Lewy-Body disease, or other neurological condition known to impact sleep
  • Current diagnosis of major psychiatric disorder (well-controlled depression or anxiety is permitted)
  • Current opiate/opioid use
  • Alcohol or drug abuse within the past year
  • Irregular sleep schedule (bedtime before 8pm/after 2am OR wake time before 4am/after 10am), unless participant states they are willing and able to change if prompted.

结局指标

主要结局

Insomnia Severity Index

时间窗: Baseline, Week 3 (Post-TMS), Week 12 (Post-CBT-I), 6 months (follow-up)

The Insomnia Severity Index (ISI) is a brief self-assessment tool used to measure the severity of insomnia. It consists of seven questions that evaluate sleep problems, their impact on daily life, and the individual's level of concern about their sleep issues. The total score helps to categorize the severity of insomnia from mild to severe.

Paired Associative Learning test (CANTAB)

时间窗: Baseline, Week 3, Week 12, 6 Months

The Paired Associative Learning (PAL) test is a computer-based cognitive assessment that evaluates memory and learning. In the test, participants are shown patterns and must remember the locations of these patterns on a screen. It is commonly used to assess spatial memory and detect early signs of memory-related conditions like Alzheimer's disease.

Spatial Working Memory test (CANTAB)

时间窗: Baseline, Week 3, Week 12, 6 months

The Spatial Working Memory (SWM) test is a computer-based task used to assess the ability to retain and manipulate spatial information. Participants must find hidden tokens within a series of boxes while avoiding revisiting previously searched locations. This test measures executive function and memory, and is often used in research on conditions affecting cognitive function.

次要结局

  • Center for Epidemiologic Studies Depression scale(Baseline, Week 3, Week 12, 6 months)
  • Multidimensional Fatigue Symptoms Inventory(Baseline, Week 3, Week 12, 6 months)
  • Center for Epidemiologic Studies Depression scale(Baseline, Week 3, Week 12, 6 months)
  • Match to Sample Visual Search test (CANTAB)(Baseline, Week 3, Week 12, 6 months)
  • Montreal Cognitive Assessment(Baseline, Week 3, Week 12, 6 months)
  • Sleep efficiency (sleep diaries)(Week 3, Week 13, 6 months)
  • Sleep After Wake Onset (sleep diaries)(Week 3, Week 13, Week 40)
  • Sleep Onset Latency (sleep diaries)(Week 3, Week 13, Week 40)
  • Sleep efficiency (actigraphy)(Week 3, Week 13, 6 months)
  • Sleep After Wake Onset (actigraphy)(Week 3, Week 13, Week 40)
  • Sleep Onset Latency (actigraphy)(Week 3, Week 13, Week 40)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peter J. Fried

Principal Investigator

Beth Israel Deaconess Medical Center

研究点 (2)

Loading locations...

相似试验